Resources
Please download this latest infographic from the National Eczema Association: Examining Out-of-Pocket Costs.
Please visit this link to view this recent article: Atopic Dermatitis Polypharmacy and Out-Of-Pocket Healthcare Expenses.
https://pubmed.ncbi.nlm.nih.gov/36745366/
Please visit this link to view this recent article: Guidelines of care for the management of atopic dermatitis in adults with topical therapies.
https://pubmed.ncbi.nlm.nih.gov/36641009/
Please visit this link to view the infographic from More Than Skin Deep regarding Eczema in Adults: Understanding Burden, Improving Options.
Please visit this link to view the infographic from More Than Skin Deep regarding The Unseen Costs of Eczema.
Please visit these links for important resources regarding out-of-pocket healthcare expenses from NEA:
Financial Burden of Atopic Dermatitis Out-of-Pocket Health Care Expenses in the United States
https://pubmed.ncbi.nlm.nih.gov/33323748/
Impact and Associations of Atopic Dermatitis Out-of-Pocket Health Care Expenses in the United States
https://pubmed.ncbi.nlm.nih.gov/34516440/
Financial burden and impact of atopic dermatitis out-of-pocket healthcare expenses among black individuals in the United States
https://pubmed.ncbi.nlm.nih.gov/34580770/
The financial burden of out-of-pocket healthcare expenses on caregivers of children with atopic dermatitis in the United States
https://onlinelibrary.wiley.com/doi/10.1002/ski2.191
To view these latest guidelines from the Journal of the American Academy of Dermatology, please visit this link: https://www.jaad.org/article/S0190-9622(22)00080-9/fulltext.
To view the latest guidelines from the AAD, please follow this link:
https://www.jaad.org/article/S0190-9622(23)00004-X/fulltext
A Patient Survey to Identify Atopic Dermatitis Prescription Treatment Access Barriers
Abstract: https://eposters.aad.org/abstracts/33247
Follow this link to view an commentary piece published in Journal of Managed Care & Specialty Pharmacy (JMCP) from Wendy Smith Begolka, MBS, Lisa Butler, MBA, and Michele Guadalupe, MPH with the National Eczema Association.
The article is titled “The ICER review is in: hope amidst uncertainty”
Please download this latest infographic from the National Eczema Association: Examining Out-of-Pocket Costs.
Please visit this link to view this recent article: Atopic Dermatitis Polypharmacy and Out-Of-Pocket Healthcare Expenses.
https://pubmed.ncbi.nlm.nih.gov/36745366/
Please visit this link to view this recent article: Guidelines of care for the management of atopic dermatitis in adults with topical therapies.
https://pubmed.ncbi.nlm.nih.gov/36641009/
Please visit this link to view the infographic from More Than Skin Deep regarding Eczema in Adults: Understanding Burden, Improving Options.
Please visit this link to view the infographic from More Than Skin Deep regarding The Unseen Costs of Eczema.
Please visit these links for important resources regarding out-of-pocket healthcare expenses from NEA:
Financial Burden of Atopic Dermatitis Out-of-Pocket Health Care Expenses in the United States
https://pubmed.ncbi.nlm.nih.gov/33323748/
Impact and Associations of Atopic Dermatitis Out-of-Pocket Health Care Expenses in the United States
https://pubmed.ncbi.nlm.nih.gov/34516440/
Financial burden and impact of atopic dermatitis out-of-pocket healthcare expenses among black individuals in the United States
https://pubmed.ncbi.nlm.nih.gov/34580770/
The financial burden of out-of-pocket healthcare expenses on caregivers of children with atopic dermatitis in the United States
https://onlinelibrary.wiley.com/doi/10.1002/ski2.191
To view these latest guidelines from the Journal of the American Academy of Dermatology, please visit this link: https://www.jaad.org/article/S0190-9622(22)00080-9/fulltext.
To view the latest guidelines from the AAD, please follow this link:
https://www.jaad.org/article/S0190-9622(23)00004-X/fulltext
A Patient Survey to Identify Atopic Dermatitis Prescription Treatment Access Barriers
Abstract: https://eposters.aad.org/abstracts/33247
Follow this link to view an commentary piece published in Journal of Managed Care & Specialty Pharmacy (JMCP) from Wendy Smith Begolka, MBS, Lisa Butler, MBA, and Michele Guadalupe, MPH with the National Eczema Association.
The article is titled “The ICER review is in: hope amidst uncertainty”
Please visit this link to view this recent article: Atopic Dermatitis Polypharmacy and Out-Of-Pocket Healthcare Expenses.
https://pubmed.ncbi.nlm.nih.gov/36745366/
Please visit this link to view this recent article: Guidelines of care for the management of atopic dermatitis in adults with topical therapies.
https://pubmed.ncbi.nlm.nih.gov/36641009/
Please visit this link to view the infographic from More Than Skin Deep regarding Eczema in Adults: Understanding Burden, Improving Options.
Please visit this link to view the infographic from More Than Skin Deep regarding The Unseen Costs of Eczema.
Please visit these links for important resources regarding out-of-pocket healthcare expenses from NEA:
Financial Burden of Atopic Dermatitis Out-of-Pocket Health Care Expenses in the United States
https://pubmed.ncbi.nlm.nih.gov/33323748/
Impact and Associations of Atopic Dermatitis Out-of-Pocket Health Care Expenses in the United States
https://pubmed.ncbi.nlm.nih.gov/34516440/
Financial burden and impact of atopic dermatitis out-of-pocket healthcare expenses among black individuals in the United States
https://pubmed.ncbi.nlm.nih.gov/34580770/
The financial burden of out-of-pocket healthcare expenses on caregivers of children with atopic dermatitis in the United States
https://onlinelibrary.wiley.com/doi/10.1002/ski2.191
To view these latest guidelines from the Journal of the American Academy of Dermatology, please visit this link: https://www.jaad.org/article/S0190-9622(22)00080-9/fulltext.
To view the latest guidelines from the AAD, please follow this link:
https://www.jaad.org/article/S0190-9622(23)00004-X/fulltext
A Patient Survey to Identify Atopic Dermatitis Prescription Treatment Access Barriers
Abstract: https://eposters.aad.org/abstracts/33247
Follow this link to view an commentary piece published in Journal of Managed Care & Specialty Pharmacy (JMCP) from Wendy Smith Begolka, MBS, Lisa Butler, MBA, and Michele Guadalupe, MPH with the National Eczema Association.
The article is titled “The ICER review is in: hope amidst uncertainty”
Please visit this link to view this recent article: Guidelines of care for the management of atopic dermatitis in adults with topical therapies.
https://pubmed.ncbi.nlm.nih.gov/36641009/
Please visit this link to view the infographic from More Than Skin Deep regarding Eczema in Adults: Understanding Burden, Improving Options.
Please visit this link to view the infographic from More Than Skin Deep regarding The Unseen Costs of Eczema.
Please visit these links for important resources regarding out-of-pocket healthcare expenses from NEA:
Financial Burden of Atopic Dermatitis Out-of-Pocket Health Care Expenses in the United States
https://pubmed.ncbi.nlm.nih.gov/33323748/
Impact and Associations of Atopic Dermatitis Out-of-Pocket Health Care Expenses in the United States
https://pubmed.ncbi.nlm.nih.gov/34516440/
Financial burden and impact of atopic dermatitis out-of-pocket healthcare expenses among black individuals in the United States
https://pubmed.ncbi.nlm.nih.gov/34580770/
The financial burden of out-of-pocket healthcare expenses on caregivers of children with atopic dermatitis in the United States
https://onlinelibrary.wiley.com/doi/10.1002/ski2.191
To view these latest guidelines from the Journal of the American Academy of Dermatology, please visit this link: https://www.jaad.org/article/S0190-9622(22)00080-9/fulltext.
To view the latest guidelines from the AAD, please follow this link:
https://www.jaad.org/article/S0190-9622(23)00004-X/fulltext
A Patient Survey to Identify Atopic Dermatitis Prescription Treatment Access Barriers
Abstract: https://eposters.aad.org/abstracts/33247
Follow this link to view an commentary piece published in Journal of Managed Care & Specialty Pharmacy (JMCP) from Wendy Smith Begolka, MBS, Lisa Butler, MBA, and Michele Guadalupe, MPH with the National Eczema Association.
The article is titled “The ICER review is in: hope amidst uncertainty”
Please visit this link to view the infographic from More Than Skin Deep regarding Eczema in Adults: Understanding Burden, Improving Options.
Please visit this link to view the infographic from More Than Skin Deep regarding The Unseen Costs of Eczema.
Please visit these links for important resources regarding out-of-pocket healthcare expenses from NEA:
Financial Burden of Atopic Dermatitis Out-of-Pocket Health Care Expenses in the United States
https://pubmed.ncbi.nlm.nih.gov/33323748/
Impact and Associations of Atopic Dermatitis Out-of-Pocket Health Care Expenses in the United States
https://pubmed.ncbi.nlm.nih.gov/34516440/
Financial burden and impact of atopic dermatitis out-of-pocket healthcare expenses among black individuals in the United States
https://pubmed.ncbi.nlm.nih.gov/34580770/
The financial burden of out-of-pocket healthcare expenses on caregivers of children with atopic dermatitis in the United States
https://onlinelibrary.wiley.com/doi/10.1002/ski2.191
To view these latest guidelines from the Journal of the American Academy of Dermatology, please visit this link: https://www.jaad.org/article/S0190-9622(22)00080-9/fulltext.
To view the latest guidelines from the AAD, please follow this link:
https://www.jaad.org/article/S0190-9622(23)00004-X/fulltext
A Patient Survey to Identify Atopic Dermatitis Prescription Treatment Access Barriers
Abstract: https://eposters.aad.org/abstracts/33247
Follow this link to view an commentary piece published in Journal of Managed Care & Specialty Pharmacy (JMCP) from Wendy Smith Begolka, MBS, Lisa Butler, MBA, and Michele Guadalupe, MPH with the National Eczema Association.
The article is titled “The ICER review is in: hope amidst uncertainty”
Please visit this link to view the infographic from More Than Skin Deep regarding The Unseen Costs of Eczema.
Please visit these links for important resources regarding out-of-pocket healthcare expenses from NEA:
Financial Burden of Atopic Dermatitis Out-of-Pocket Health Care Expenses in the United States
https://pubmed.ncbi.nlm.nih.gov/33323748/
Impact and Associations of Atopic Dermatitis Out-of-Pocket Health Care Expenses in the United States
https://pubmed.ncbi.nlm.nih.gov/34516440/
Financial burden and impact of atopic dermatitis out-of-pocket healthcare expenses among black individuals in the United States
https://pubmed.ncbi.nlm.nih.gov/34580770/
The financial burden of out-of-pocket healthcare expenses on caregivers of children with atopic dermatitis in the United States
https://onlinelibrary.wiley.com/doi/10.1002/ski2.191
To view these latest guidelines from the Journal of the American Academy of Dermatology, please visit this link: https://www.jaad.org/article/S0190-9622(22)00080-9/fulltext.
To view the latest guidelines from the AAD, please follow this link:
https://www.jaad.org/article/S0190-9622(23)00004-X/fulltext
A Patient Survey to Identify Atopic Dermatitis Prescription Treatment Access Barriers
Abstract: https://eposters.aad.org/abstracts/33247
Follow this link to view an commentary piece published in Journal of Managed Care & Specialty Pharmacy (JMCP) from Wendy Smith Begolka, MBS, Lisa Butler, MBA, and Michele Guadalupe, MPH with the National Eczema Association.
The article is titled “The ICER review is in: hope amidst uncertainty”
Please visit these links for important resources regarding out-of-pocket healthcare expenses from NEA:
Financial Burden of Atopic Dermatitis Out-of-Pocket Health Care Expenses in the United States
https://pubmed.ncbi.nlm.nih.gov/33323748/
Impact and Associations of Atopic Dermatitis Out-of-Pocket Health Care Expenses in the United States
https://pubmed.ncbi.nlm.nih.gov/34516440/
Financial burden and impact of atopic dermatitis out-of-pocket healthcare expenses among black individuals in the United States
https://pubmed.ncbi.nlm.nih.gov/34580770/
The financial burden of out-of-pocket healthcare expenses on caregivers of children with atopic dermatitis in the United States
https://onlinelibrary.wiley.com/doi/10.1002/ski2.191
To view these latest guidelines from the Journal of the American Academy of Dermatology, please visit this link: https://www.jaad.org/article/S0190-9622(22)00080-9/fulltext.
To view the latest guidelines from the AAD, please follow this link:
https://www.jaad.org/article/S0190-9622(23)00004-X/fulltext
A Patient Survey to Identify Atopic Dermatitis Prescription Treatment Access Barriers
Abstract: https://eposters.aad.org/abstracts/33247
Follow this link to view an commentary piece published in Journal of Managed Care & Specialty Pharmacy (JMCP) from Wendy Smith Begolka, MBS, Lisa Butler, MBA, and Michele Guadalupe, MPH with the National Eczema Association.
The article is titled “The ICER review is in: hope amidst uncertainty”
To view these latest guidelines from the Journal of the American Academy of Dermatology, please visit this link: https://www.jaad.org/article/S0190-9622(22)00080-9/fulltext.
To view the latest guidelines from the AAD, please follow this link:
https://www.jaad.org/article/S0190-9622(23)00004-X/fulltext
A Patient Survey to Identify Atopic Dermatitis Prescription Treatment Access Barriers
Abstract: https://eposters.aad.org/abstracts/33247
Follow this link to view an commentary piece published in Journal of Managed Care & Specialty Pharmacy (JMCP) from Wendy Smith Begolka, MBS, Lisa Butler, MBA, and Michele Guadalupe, MPH with the National Eczema Association.
The article is titled “The ICER review is in: hope amidst uncertainty”
To view the latest guidelines from the AAD, please follow this link:
https://www.jaad.org/article/S0190-9622(23)00004-X/fulltext
A Patient Survey to Identify Atopic Dermatitis Prescription Treatment Access Barriers
Abstract: https://eposters.aad.org/abstracts/33247
Follow this link to view an commentary piece published in Journal of Managed Care & Specialty Pharmacy (JMCP) from Wendy Smith Begolka, MBS, Lisa Butler, MBA, and Michele Guadalupe, MPH with the National Eczema Association.
The article is titled “The ICER review is in: hope amidst uncertainty”
A Patient Survey to Identify Atopic Dermatitis Prescription Treatment Access Barriers
Abstract: https://eposters.aad.org/abstracts/33247
Follow this link to view an commentary piece published in Journal of Managed Care & Specialty Pharmacy (JMCP) from Wendy Smith Begolka, MBS, Lisa Butler, MBA, and Michele Guadalupe, MPH with the National Eczema Association.
The article is titled “The ICER review is in: hope amidst uncertainty”
Follow this link to view an commentary piece published in Journal of Managed Care & Specialty Pharmacy (JMCP) from Wendy Smith Begolka, MBS, Lisa Butler, MBA, and Michele Guadalupe, MPH with the National Eczema Association.
The article is titled “The ICER review is in: hope amidst uncertainty”